BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 14978245)

  • 1. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.
    Guo J; Ikeda SR
    Mol Pharmacol; 2004 Mar; 65(3):665-74. PubMed ID: 14978245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
    McAllister SD; Griffin G; Satin LS; Abood ME
    J Pharmacol Exp Ther; 1999 Nov; 291(2):618-26. PubMed ID: 10525080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
    Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
    Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
    Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
    Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.
    Twitchell W; Brown S; Mackie K
    J Neurophysiol; 1997 Jul; 78(1):43-50. PubMed ID: 9242259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
    Pan X; Ikeda SR; Lewis DL
    Mol Pharmacol; 1996 Apr; 49(4):707-14. PubMed ID: 8609900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
    Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
    J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
    Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels.
    Romano MR; Lograno MD
    Br J Pharmacol; 2006 Apr; 147(8):917-25. PubMed ID: 16474412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous expression and coupling of G protein-gated inwardly rectifying K+ channels in adult rat sympathetic neurons.
    Ruiz-Velasco V; Ikeda SR
    J Physiol; 1998 Dec; 513 ( Pt 3)(Pt 3):761-73. PubMed ID: 9824716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons.
    Fisyunov A; Tsintsadze V; Min R; Burnashev N; Lozovaya N
    J Neurophysiol; 2006 Sep; 96(3):1267-77. PubMed ID: 16738209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.
    Gebremedhin D; Lange AR; Campbell WB; Hillard CJ; Harder DR
    Am J Physiol; 1999 Jun; 276(6):H2085-93. PubMed ID: 10362691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Kir3.1, Kir3.2A and Kir3.2C subunits to native G protein-gated inwardly rectifying potassium currents in cultured hippocampal neurons.
    Leaney JL
    Eur J Neurosci; 2003 Oct; 18(8):2110-8. PubMed ID: 14622172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.
    Vásquez C; Navarro-Polanco RA; Huerta M; Trujillo X; Andrade F; Trujillo-Hernández B; Hernández L
    Can J Physiol Pharmacol; 2003 May; 81(5):436-42. PubMed ID: 12774849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S; Venance L; Torrens Y; Cordier J; Glowinski J; Giaume C
    Eur J Neurosci; 1999 Feb; 11(2):691-9. PubMed ID: 10051770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of alpha 2-adrenoceptors causes inhibition of calcium channels but does not modulate inwardly-rectifying K+ channels in caudal raphe neurons.
    Li YW; Bayliss DA
    Neuroscience; 1998 Feb; 82(3):753-65. PubMed ID: 9483533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing.
    Eroli F; Loonen ICM; van den Maagdenberg AMJM; Tolner EA; Nistri A
    Neuropharmacology; 2018 Mar; 131():39-50. PubMed ID: 29225040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.
    Nicholson RA; Liao C; Zheng J; David LS; Coyne L; Errington AC; Singh G; Lees G
    Brain Res; 2003 Jul; 978(1-2):194-204. PubMed ID: 12834914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.